LAVA Therapeutics N.V. (LVTX) Financials
Stock symbol LVTX is outdated, potentially delisted? Maybe it is available on other exchange?
LVTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 71.2 million | 45.4 million |
| Dec. 31, 2024 | 80.8 million | 53.1 million |
| Sept. 30, 2024 | 83.4 million | 50.4 million |
| June 30, 2024 | 92.3 million | 49.4 million |
LVTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | 2.0 million | 540000 |
| Dec. 31, 2024 | -1.4 million | 590000 |
| Sept. 30, 2024 | -8.7 million | 720000 |
| June 30, 2024 | -8.4 million | 821000 |
LVTX Net Income
No data available :(
LVTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 66.6 million | 6000 | 312000 |
| Dec. 31, 2024 | 76.6 million | 80000 | 395000 |
| Sept. 30, 2024 | 78.9 million | 164000 | 534000 |
| June 30, 2024 | 86.8 million | 295000 | 780000 |
LVTX Shares Outstanding
LVTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | - | 4.2 million | 3.4 million | - |
| Dec. 31, 2024 | - | 7.6 million | 4.5 million | - |
| Sept. 30, 2024 | 23000 | 8.5 million | 2.8 million | - |
| June 30, 2024 | 3 | 6.3 million | 3.0 million | 228000 |
LVTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | - | - |
| Dec. 31, 2024 | 5.0 million | 228000 |
| Sept. 30, 2024 | - | - |
| June 30, 2024 | 227999 | 228000 |
LVTX
Price: $1.74
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.87 USD
P/E Ratio: -2
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 12191
Market Capitalization: 45.8 million